519060-62-9Relevant academic research and scientific papers
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: Modifications of the arylpropylpiperidine side chains
Lynch, Christopher L.,Willoughby, Christopher A.,Hale, Jeffrey J.,Holson, Edward J.,Budhu, Richard J.,Gentry, Amy L.,Rosauer, Keith G.,Caldwell, Charles G.,Chen, Ping,Mills, Sander G.,MacCoss, Malcolm,Berk, Scott,Chen, Liya,Chapman, Kevin T.,Malkowitz, Lorraine,Springer, Martin S.,Gould, Sandra L.,DeMartino, Julie A.,Siciliano, Salvatore J.,Cascieri, Margaret A.,Carella, Anthony,Carver, Gwen,Holmes, Karen,Schleif, William A.,Danzeisen, Renee,Hazuda, Daria,Kessler, Joseph,Lineberger, Janet,Miller, Michael,Emini, Emilio A.
, p. 119 - 123 (2007/10/03)
The 4-(3-phenylprop-1-yl)piperidine moiety of the 1,3,4-trisubstituted pyrrolidine CCR5 antagonist 1 was modified with electron deficient aromatics as well as replacement of the benzylic methylene with sulfones, gem-difluoromethylenes and alcohols in an effort to balance the antiviral potency with reasonable pharmacokinetics.
